LRRK2 and Parkinson disease: A number of studies have shown that peripheral pro-inflammatory cytokine responses to challenge were altered in mice carrying the LRRK2 mutation35–37 as well as in asymptomatic PD patients carrying a G2019S LRRK2 mutation38; suggesting a role for LRRK2 in peripheral inflammation.